VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NEO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NEONeoGenomics, Inc.
$15.29$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNEOBalance Sheet

NeoGenomics, Inc. (NEO) Balance Sheet

26Y historyFree accessUpdated daily

Total debt declined to $449.1M from $606.5M over ten quarters, lowering the debt-to-equity ratio to 0.56, while cash thinned to $139.3M and goodwill of $524.0M dominates the asset base.

Income StatementBalance SheetCash FlowRatios

NEO Balance Sheet

Annual statement

NEO Balance Sheet

NeoGenomics, Inc. (NEO) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Total Current Assets410.08M376.29M596.02M596.81M605.29M681.51M448.73M290.74M103.67M84.96M78.83M99.03M58.74M27.49M18.58M13.18M8.74M8.52M4.36M4.15M1.9M680.55K196.28K102.13K61.39K78.52K186
Cash & Short-Term Investments139.28M159.62M386.84M415.2M437.99M515.39M296.26M173.02M9.81M12.82M12.53M23.42M33.69M4.83M1.87M2.63M1.1M1.63M468.17K210.57K126.27K10.94K112.55K25.05K077.22K186
Cash Only139.28M159.62M367.01M342.49M263.18M316.83M228.71M173.02M9.81M12.82M12.53M23.42M33.69M4.83M1.87M2.63M1.1M1.63M468.17K210.57K126.27K10.94K112.55K25.05K077.22K186
Short-Term Investments0019.83M72.72M174.81M198.56M67.55M00000000000000000000
Accounts Receivable213.41M159.24M150.54M131.26M119.71M112.13M106.84M95.24M76.92M60.43M55.51M48.94M20.48M18.65M14.03M7.89M5.24M4.63M2.91M3.24M1.55M551.1K56.49K63.86K40.08K00
Days Sales Outstanding82.8879.9183.1880.9885.7284.587.7485.03101.4591.883.0117985.83102.4385.5666.2655.657.3753.13102.6987.35106.7136.9563156.48--
Inventory25.5M28.57M26.75M24.16M24.28M23.39M29.53M14.4M8.65M7.47M6.25M5.11M2.62M2.3M1.86M1.2M887K601.8K491.46K304.75K117.36K60K15.12K10.59K19.31K00
Days Inventory Outstanding22.8923.4426.3525.4127.5328.7341.6824.821.1219.7317.0733.2720.624.1820.5418.2417.4215.4119.1820.1415.5318.439.578.0337.1--
Other Current Assets9.12M7.42M11.72M8.2M8.08M18.24M4.55M1.75M561K1M4.54M4.89M1.96M1.7M820K1.45M1.52M1.66M482.41K400.17K102.17K58.51K12.12K2.63K2K1.3K0
Total Non-Current Assets966.83M983.54M1.04B1.08B1.13B1.19B539.6M418.77M401.35M258.38M258.29M268.93M22.36M12.43M11.49M6.77M4.91M4.43M2.94M2.37M1.24M399.55K395.72K404.91K386.45K2.83K0
Property, Plant & Equipment170.21M163.28M173.69M183.78M198.61M211.66M151.89M90.68M60.89M36.5M34.04M34.58M15.08M9.69M8.61M6.64M4.84M4.34M2.88M2.11M1.2M381.56K393.04K397.69K382.54K2.83K0
Fixed Asset Turnover4.77x4.45x3.80x3.22x2.57x2.29x2.93x4.51x4.55x6.58x7.17x2.89x5.77x6.86x6.96x6.55x7.10x6.79x6.96x5.46x5.39x4.94x1.42x0.93x0.24x0.35x-
Goodwill524M524.34M522.77M522.77M522.77M527.12M211.08M198.6M197.89M147.02M147.02M146.42M2.93M00000000000000
Intangible Assets263.63M286.53M339.68M373.13M408.26M442.32M120.65M126.64M140.03M74.17M77.06M87.8M4.21M2.58M2.8M000000000000
Long-Term Investments000031K236K29.55M153K-22.46M-6.31M-14.97M-16.67M000000000000000
Other Non-Current Assets9M9.39M5.89M4.74M-29.67M-48.54M21.01M2.69M2.54M689K174K129K141K154K83K129K74K85.6K64.51K260.57K33.9K18K2.68K7.22K3.92K00
Total Assets1.38B1.36B1.64B1.68B1.74B1.87B988.33M709.51M505.01M343.34M337.12M367.95M81.11M39.92M30.07M19.95M13.65M12.95M7.3M6.52M3.13M1.08M592K507.04K447.84K81.34K186
Asset Turnover0.58x0.53x0.40x0.35x0.29x0.26x0.45x0.58x0.55x0.70x0.72x0.27x1.07x1.67x1.99x2.18x2.52x2.28x2.74x1.76x2.07x1.75x0.94x0.73x0.21x0.01x1357.01x
Asset Growth %-35.74%-16.98%-2.57%-3.38%-6.94%89.19%39.3%40.49%47.09%1.85%-8.38%353.67%103.19%32.74%50.74%46.14%5.45%77.45%11.88%108.21%189.97%82.45%16.76%13.22%450.56%43632.8%-
Total Current Liabilities116.17M88.3M301.24M96.3M89.93M87.23M73.18M63.9M60.92M35.06M59.91M40.06M14.62M14.32M17.76M11.44M9.17M5.78M4.39M3.36M2.63M665.85K1.02M284.84K424.49K186.22K125.03K
Accounts Payable32.92M23.09M21.61M20.33M20.51M17.92M24.96M19.57M17.78M10.45M16.78M12.46M6.29M4.18M3.61M2.53M1.93M1.97M1.51M1.8M697.75K463.64K96.21K70.34K119.84K19.3K10.46K
Days Payables Outstanding37.5918.9521.2921.3923.262235.2433.6943.4127.5845.8181.1749.5643.939.938.3737.9650.4259.02118.992.31142.4560.8753.31230.27-51.39
Short-Term Debt04.78M200.78M001.14M2.84M13.81M14.17M3.8M3.84M9.47M66K4.28M8.46M3.9M3.44M552K1.15M242.97K1.73M00013.52K00
Deferred Revenue (Current)828K0409K2.13M7.56M5.19M4.03M1.61M927K-15.63M-12.6M-13.59M0000000944.58K200.59K100K110K110K100K00
Other Current Liabilities060.43M62.44M53.16M15.07M16.66M07.55M2.69M1.41M000741K669K773K460K465.07K358.26K949.08K67.1K59.66K740K58.67K191.14K157.31K114.57K
Current Ratio3.53x4.26x1.98x6.20x6.73x7.81x6.13x4.55x1.70x2.42x1.32x2.47x4.02x1.92x1.05x1.15x0.95x1.48x0.99x1.24x0.72x1.02x0.19x0.36x0.14x0.42x0.00x
Quick Ratio3.31x3.94x1.89x5.95x6.46x7.54x5.73x4.32x1.56x2.21x1.21x2.34x3.84x1.76x0.94x1.05x0.86x1.37x0.88x1.14x0.68x0.93x0.18x0.32x0.10x0.42x0.00x
Cash Conversion Cycle68.1884.4188.258589.9991.2294.1876.1479.1683.9554.27131.0956.8782.7266.246.1335.0622.3713.293.9310.56-17.3-14.3617.72-36.69--
Total Non-Current Liabilities460.11M434.97M434.46M643.39M652.08M674.27M220.85M138.19M123.65M102.74M90.61M89.78M6.08M3.88M3.1M2.61M1.35M1.53M1.4M837.08K448.95K1.41M206.21K590K233.36K19.3K10.46K
Long-Term Debt374.69M404.68M340.33M538.2M535.32M532.48M168.12M91.83M98.13M91.15M92.06M52.34M64K0000000000590K000
Capital Lease Obligations261.44M62.82M60.84M67.87M68.95M72.29M43.26M27.23M05.28M5.38M5.04M5.19M3.29M3.1M2.61M1.35M1.53M1.4M837.08K448.95K1.41M00000
Deferred Tax Liabilities68.59M18.22M21.51M24.29M34.75M55.48M5.42M15.57M22.46M6.31M14.97M32.41M821K588K0000000000000
Other Non-Current Liabilities867K-51.14M11.77M13.03M13.05M13.03M3.34M2.4M3.06M6.97M0000000-272000000000
Total Liabilities576.28M523.27M735.7M739.69M742.01M761.5M294.04M202.1M184.57M137.81M150.52M129.84M20.7M18.2M20.86M14.05M10.52M7.3M5.79M4.2M3.08M2.08M1.02M874.84K424.49K186.22K125.03K
Total Debt449.14M472.28M605.33M611.68M610.93M612.79M218.22M132.88M112.3M105.42M106.17M71.38M8.48M10.36M13.77M8.61M6.79M3.56M3.19M1.08M543.38K00590K13.52K00
Net Debt309.86M312.66M238.32M269.19M347.75M295.96M-10.49M-40.14M102.49M92.6M93.64M47.96M-25.21M5.53M11.9M5.99M5.69M1.93M2.72M869.47K417.11K-10.94K-112.55K564.95K13.52K-77.22K-186
Debt / Equity0.56x0.56x0.67x0.65x0.61x0.55x0.31x0.26x0.35x0.51x0.57x0.30x0.14x0.48x1.49x1.46x2.16x0.63x2.12x0.47x9.97x---0.58x--
Debt / EBITDA24.80x270.65x----10.04x3.07x3.53x4.14x4.12x47.36x1.08x1.37x2.74x5.14x----1.22x------
Net Debt / EBITDA17.11x179.17x-----0.48x-0.93x3.23x3.63x3.63x31.82x-3.21x0.73x2.37x3.57x----0.93x------
Interest Coverage-10.15x-28.38x-11.19x-13.06x-20.02x-0.83x-1.00x1.98x1.61x0.71x0.22x-4.26x2.25x3.21x1.06x-0.53x-4.17x-3.25x-2.87x-0.43x-4.07x--11.92x-2.82x--
Total Equity800.64M836.56M902.34M941.54M998.02M1.11B694.29M507.41M320.44M205.53M186.6M238.11M60.41M21.71M9.22M5.9M3.13M5.64M1.5M2.32M54.51K-994.94K-426.65K-367.8K23.34K-104.87K-124.84K
Equity Growth %-26.48%-7.29%-4.16%-5.66%-9.95%59.63%36.83%58.35%55.91%10.15%-21.64%294.19%178.22%135.58%56.28%88.1%-44.45%275.94%-35.36%4159.67%105.48%-133.2%-16%-1675.51%122.26%16%-
Book Value per Share6.236.537.127.508.039.246.214.903.502.592.4119.675.392.060.950.690.420.810.240.370.01-0.22-0.10-0.130.03-0.14-0.80
Total Shareholders' Equity800.64M836.56M902.34M941.54M998.02M1.11B694.29M507.41M320.44M205.53M186.6M238.11M60.41M21.71M9.22M5.9M3.13M5.64M1.5M2.32M54.51K-994.94K-426.65K-367.8K23.34K-104.87K-124.84K
Common Stock131K129K128K127K127K124K112K105K94K80K79K76K60K49K45K43K37K37.19K32.12K31.39K27.06K22.84K21.54K18.45K4.48K405K1.32M
Retained Earnings-456.22M-433.81M-325.78M-247.06M-159.09M-14.84M-7.18M-11.36M-51.26M-57.47M-52.46M-21.94M-19.41M-20.54M-22.57M-22.64M-21.46M-18.16M-15.91M-14.53M-11.15M-11.02M-10.02M-8.67M-8.67M-8.08M-1.45M
Treasury Stock-25M00000000000000000000000000
Accumulated OCI4K4K-206K-1.67M-3.9M-638K10K-1.62M-579K274K-27.1M-26.53M-19.82M-14.48M-10.29M-6.65M-4.57M-2.79M00-122.62K-2.69K-28.62K-535.76K-38.36K-3.79M0
Minority Interest000000000000000000000000000

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Thin cash buffer against debt

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Balance Sheet Shifted Toward Lower Leverage

Based on NEO's reported figures, total debt fell from $606.5M in 2024Q2 to $449.1M in 2026Q3 while equity rose from $915.9M to $800.6M, reflecting a deleveraging trend over the ten-quarter window.

The reduction in debt appears to have been funded partly from a cash drawdown, with cash falling from $355.1M to $139.3M over the same period. This pattern suggests the company prioritized paying down obligations over building reserves, which may improve the leverage profile but reduces its shock absorption capacity. Investors should monitor whether further debt reduction can be sustained without additional cash burn.

Leverage Moderate but Refinancing Visibility Limited

As reported in financial statements, NEO's debt-to-equity ratio improved from 0.66 in 2024Q2 to 0.56 in 2026Q3, with total debt of $449.1M against equity of $800.6M.

A D/E near 0.56 is moderate for a company with persistent operating losses, suggesting leverage is not currently excessive relative to book equity. However, the book equity base is heavily influenced by goodwill of $524.0M, so tangible equity may be considerably lower than headline figures imply. The filings provided do not disclose maturity schedules, so refinancing risk cannot be fully assessed from this data.

Current Ratio Strong but Cash Thinning

Based on NEO's reported figures, the current ratio stands at 3.53 in 2026Q3, though cash has declined to $139.3M from $346.2M a year earlier, narrowing the liquidity cushion.

A current ratio above 3.5 indicates substantial short-term asset coverage, but the ratio is partly sustained by receivables and inventory whose conversion to cash is not fully visible in the supplied data. The sharp cash decline in 2025Q1 coincided with debt reduction, leaving less direct liquidity against operating cash swings. Investors should monitor whether cash stabilizes given the historically volatile free cash flow profile.

Goodwill Dominates Asset Base

According to reported figures, goodwill of $524.0M represents a large share of NEO's roughly $1.4B total assets, while net PP&E remains modest at $170.2M.

The asset mix suggests a business whose balance sheet value rests heavily on acquired intangibles rather than physical capacity, which is consistent with a diagnostics services model. Goodwill has been essentially flat across the period, so impairment risk depends on whether future earnings support the carrying value given persistent operating losses. PP&E has been broadly stable, indicating capital intensity is not the primary driver of balance sheet change.

Goodwill Could Overstate Balance Sheet Strength

Based on reported figures, NEO's accumulated deficit of -$456.2M and goodwill of $524.0M together suggest the headline equity of $800.6M may be more dependent on acquisition accounting than on retained operating value.

Because retained earnings are deeply negative, the positive equity position appears to rest on paid-in capital rather than accumulated profits. If goodwill were ever written down, reported equity could fall sharply, which may alter leverage metrics even without any change in debt. This distortion warrants further investigation before treating the current D/E as a reliable measure of financial resilience.

NEO — Frequently Asked Questions

Quick answers to the most common questions about buying NEO stock.

What are the total assets of NeoGenomics, Inc. (NEO)?

As of 2025, NeoGenomics, Inc. (NEO) had total assets of $1.36B including $376.3M in current assets.

How much debt does NeoGenomics, Inc. (NEO) have?

NeoGenomics, Inc. (NEO) carries total debt of $472.3M, offset by $159.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of NeoGenomics, Inc.?

NeoGenomics, Inc. (NEO) has total shareholders' equity (book value) of $836.6M ($6.53 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is NeoGenomics, Inc.'s current ratio and liquidity?

NeoGenomics, Inc. (NEO) reported a current ratio of 4.26x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.